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Abstract
The mechanisms generating stably differentiated cell-types from multipotent precursors are key to understanding normal
development and have implications for treatment of cancer and the therapeutic use of stem cells. Pigment cells are a major
derivative of neural crest stem cells and a key model cell-type for our understanding of the genetics of cell differentiation.
Several factors driving melanocyte fate specification have been identified, including the transcription factor and master
regulator of melanocyte development, Mitf, and Wnt signalling and the multipotency and fate specification factor, Sox10,
which drive mitf expression. While these factors together drive multipotent neural crest cells to become specified
melanoblasts, the mechanisms stabilising melanocyte differentiation remain unclear. Furthermore, there is controversy over
whether Sox10 has an ongoing role in melanocyte differentiation. Here we use zebrafish to explore in vivo the gene
regulatory network (GRN) underlying melanocyte specification and differentiation. We use an iterative process of
mathematical modelling and experimental observation to explore methodically the core melanocyte GRN we have defined.
We show that Sox10 is not required for ongoing differentiation and expression is downregulated in differentiating cells, in
response to Mitfa and Hdac1. Unexpectedly, we find that Sox10 represses Mitf-dependent expression of melanocyte
differentiation genes. Our systems biology approach allowed us to predict two novel features of the melanocyte GRN, which
we then validate experimentally. Specifically, we show that maintenance of mitfa expression is Mitfa-dependent, and
identify Sox9b as providing an Mitfa-independent input to melanocyte differentiation. Our data supports our previous
suggestion that Sox10 only functions transiently in regulation of mitfa and cannot be responsible for long-term
maintenance of mitfa expression; indeed, Sox10 is likely to slow melanocyte differentiation in the zebrafish embryo. More
generally, this novel approach to understanding melanocyte differentiation provides a basis for systematic modelling of
differentiation in this and other cell-types.
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Introduction
Understanding the mechanisms of generation of differentiated
cell-types from multipotent precursors is a fundamental aspect of
development, with profound implications for the therapeutic use of
stem cells. Whilst numerous transcription factors mediating fate
choice from stem cells have been characterised, we still lack a
robust understanding of how these factors and their target
differentiation genes interact to form the gene regulatory networks
(GRNs) that result in stable differentiation. At the time of fate
specification, a multipotent cell’s GRN is configured so as to allow
multiple fates to be chosen; after specification this GRN must shift
to a new stable state to establish commitment to, and full
differentiation of, a specific fate. Tour de force studies of the early
development of the sea urchin embryo have become perhaps the
most completely understood example [1]. These studies, amongst
others, have identified two key themes of fate specification, that the
adopted fate becomes stabilized by factors initiating positive
feedback loops and that these then are reinforced by activation of
repressors of alternative fates [2]. Increasingly it is becoming clear
that mathematical modelling of these proposed networks is very
informative for a rigorous understanding of their properties [3–5],
but this remains rare, especially for vertebrate systems.
Vertebrate melanocytes (melanophores in fish, amphibians and
reptiles) are critical for body pigmentation and play roles, for
example, in mate recognition and protection against UV light.
Numerous diseases result from failures of melanocyte specification
(e.g. Waardenburg syndromes), differentiation (albinism), survival
(vitiligo) or control of proliferation (melanoma) [6]. Melanocytes
are genetically amongst the best characterised cell-types, with a
long history of genetic analysis in mammals [7], but so far these
data have not been used to generate mathematical models of
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melanocyte differentiation. Embryonic melanocytes are derived
from the neural crest [8–10] and in the adult are renewed from
dormant melanocyte stem cells [11]. Melanocyte specification
centers on the transcriptional activation of Mitf, a bHLH-LZ
transcription factor that is a master regulator of melanocyte
differentiation [12,13]. Key target genes of Mitf include those
encoding the melanogenic enzymes Dopachrome tautomerase
(Dct), Tyrosinase (Tyr) and Tyrosinase-related protein 1 (Tyrp1)
and the melanosome structural protein Silver (Si). The Sox
transcription factor Sox10 is also crucial for melanocyte
development, where it contributes to melanocyte fate-specification
by transcriptional activation of Mitf, consistent with the association
of SOX10 with Waardenburg syndrome in humans [14–20].
Given that both MITF and SOX10 are frequently mutated in
melanoma [21] and that MITF itself is considered to be a lineage
addiction oncogene [22], understanding the melanocyte GRN is of
crucial importance. However, controversy surrounds the precise
role of Sox10, with in vivo data from zebrafish arguing that an
ongoing role in melanocyte differentiation is not required in this
organism [16], while in vitro data from mouse indicates that Sox10
may contribute to expression of melanocyte differentiation genes,
Dct and Tyr [23–27]. We here combine experimental and
mathematical modelling approaches to examine this issue in more
detail in zebrafish.
We document the rapid loss of Sox10 from differentiating
melanocytes in zebrafish embryos. We adapt a simple GRN model
of sympathetic neuron development to the melanocyte case and
assess its validity both experimentally and by mathematical
modelling. This melanocyte model predicts that Sox10 represses
expression of melanocyte differentiation genes, and that in this
way Sox10 antagonizes Mitfa-mediated differentiation. Our
analysis of gene expression patterns in zebrafish sox10 and mitfa
mutants provides strong support for this, and overexpression
studies in zebrafish embryos confirm the repressive action of
Sox10 on Mitfa-mediated transcription. The model also predicts
that the turning off of sox10 expression in differentiating
melanocytes results from Mitfa-dependent repression of sox10
transcription. We provide evidence that Mitfa can regulate sox10
expression and that in vivo this effect is likely to be repressive and
dependent upon Hdac1 function. We use simple mathematical
modelling of this GRN, in conjunction with our previous
experimental data, to establish that it is insufficient to explain
stable melanocyte differentiation. We show that addition of further
features, including a Sox10-independent positive feedback loop
regulating mitfa, and a Sox10-independent weak activator of
melanocyte differentiation gene expression, are sufficient to alter
the GRN behaviour to allow stable differentiation of this cell-type
and to explain our in vivo observations. Finally, we provide genetic
evidence that Sox9b contributes to the second of these factors. The
mathematical modelling of the melanocyte GRN proposed here
provides the first such model for this important and well-
characterised cell-type and provides the basis for future qualitative
and quantitative refinement of our understanding of melanocyte
differentiation. Our data supports the previous suggestion that
Sox10 only functions transiently in mitfa expression and cannot be
responsible for long-term maintenance of mitfa expression in
zebrafish; indeed, Sox10 is likely to slow melanocyte differentiation
in the embryo. This work has clear implications for the proposed
model of sympathetic neuron differentiation, but also more
broadly for our understanding of commitment to specific fates.
Furthermore, these studies emphasize the importance of robust
mathematical modelling of proposed GRNs to test their behaviour
in a rigorous and quantitative manner.
Results
Sox10 expression is rapidly lost in differentiating
melanocytes
Our previous studies have shown that sox10 mRNA expression
is rapidly lost from differentiating sensory neurons [28]. We asked
whether this pattern was seen for sox10 expression in differenti-
ating melanocytes too. We used both whole-mount in situ
hybridisation and immunofluorescence using a Sox10 antibody
(kind gift of B. Appel) to evaluate the temporal persistence of
Sox10 expression throughout a time-course (Figure 1). Melano-
cytes were selected at random from all dorso-ventral positions
between the edge of the yolk and the end of the yolk sac extension.
Expression was scored as the percentage of melanised cells
showing detectable signal. The earliest signs of melanisation in
trunk melanocytes in wild-type embryos are seen around 27 hpf
[29]. At 30 hpf, almost all melanocytes showed detectable sox10
and Sox10 expression, but this rapidly decreased, so that by c.
50 hpf, signal was not detected in any cells. This contrasts with the
continuing expression of mitfa (data not shown and see Figure S3).
We note that at this stage, melanocyte differentiation and
melanisation is still incomplete, and we conclude that expression
of Sox10 is rapidly downregulated in differentiating melanocytes in
zebrafish.
Studies in mouse have not documented the temporal changes in
Sox10 expression in vivo, but in adult human melanocytes there is
evidence that SOX9 expression may partially replace SOX10 and
is necessary for maintenance of melanocyte differentiation [30].
Strikingly, studies of cultured differentiating human melanoblasts
show that SOX10 expression is lost in differentiating melanocytes,
but that SOX9 expression is upregulated [31]. Neither of the
zebrafish orthologues, sox9a and sox9b, have been reported as
expressed in melanocytes [32,33,34]. To assess directly whether a
similar shift from sox10 to sox9 expression might occur in zebrafish
melanocytes, we used whole-mount in situ hybridisation to assess
sox9a and sox9b expression in zebrafish embryos, but found no
evidence for such expression between 24 hpf and 72 hpf (Figure
S1; data not shown). We conclude that in zebrafish embryos, sox10
Author Summary
In a multicellular organism, one genome is used to make
numerous different cell-types. This must require the
activity of all these genes to be configured into multiple
distinct and stable active states, each corresponding to
one of the different cell-types characteristic of a tissue. The
stable active states of differentiated cell-types contrast
with the different, and transient, states characteristic of
multipotent stem cells. We know little of the key features
of these states that regulate the switch of a stem cell to
stable differentiation. Here we examine this issue in the
melanocyte, a genetically well-characterised cell-type,
using a combination of dynamic mathematical modelling
and experimental manipulation. In humans, disruption of
the melanocyte state results in congenital and degener-
ative pigmentary diseases, whereas their destabilisation is
likely to be an important factor in initiating melanoma. Our
work predicts, validates, and identifies several novel
features to the gene regulatory network of the zebrafish
melanocyte, including one stabilising the differentiated
state. Our study demonstrates the utility of this systems
biology approach to understanding the genetic basis for
differentiated cell states.
Melanocyte Gene Regulatory Network
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expression is lost from differentiating melanocytes, but this is not
replaced by sox9 gene expression.
A simple model for melanocyte development in zebrafish
This pattern of sox10 expression attenuation during neural crest
differentiation has also been described for the sympathetic neurons
in mouse (Figure 2A; [35]). These authors suggested a model
whereby Sox10-mediated activation of MASH-1 and Phox2B
drives sympathetic neuron specification, whilst initially feed-
forward repression by Sox10 delays sympathetic neuron differen-
tiation; subsequently negative feedback by MASH-1/Phox2B
turns off Sox10 and differentiation can now proceed. In
melanocyte development, Sox10 drives mitfa expression; we have
shown in zebrafish that the interaction is direct and identified
some of the relevant Sox10-binding sites in the mitfa promoter
[16]. We asked to what extent the Kim et al. model could be
generalised to another neural crest derivative. We proposed an
analogous initial model of melanocyte differentiation in which
Sox10 drives fate specification by activating mitfa expression, but
perhaps delayed melanocyte differentiation by a feed-forward
repression (Figure 2B). Based on this analogy, we made two
predictions. Firstly, melanocyte differentiation genes might be
derepressed in sox10 mutants, just as, in Sox10 mutant mice,
Phox2A expression is seen in the absence of MASH-1/Phox2B.
Secondly, that sox10 repression would be directly or indirectly
dependent upon mitfa expression. Here we explore these
predictions experimentally.
Residual melanin is observed in sox10 mutant zebrafish
embryos
We had previously observed residual melanin in dorsal positions
of 3 dpf zebrafish sox10mutants, but had not examined this trait in
detail [16]. Surprisingly, we had shown genetically that this
residual melanin was independent of mitfa function; thus, it was
consistent with possible derepression of melanocyte differentiation
genes in sox10 mutants. We examined three series of sox10 mutant
embryos, documenting the timing and appearance of these cells
(Figure S2). Melanisation in these mutants is substantially delayed
compared with wild-type siblings. In contrast to wild-type siblings
which showed faint melanin from c. 25 hpf, we were unable to
detect melanin before 36 hpf in any of 29 embryos followed
(Figure S2C). As in wild-types, numbers of melanised cells
increased with developmental age, and tended to form in an
anterior-posterior progression (data not shown). Melanised cells
were scored for their position with respect to the trunk and tail
segments defined by the myotome. The numbers were very
variable, with occasional embryos developing melanised cells in up
to 21 segments (n = 1), whereas others never showed any (n= 2),
and they were usually confined to the trunk and anterior-most tail,
and never seen in the posterior-most tail (Figure S2C and data not
shown). As noted before, melanin is very faint in these cells, but it
undergoes a dynamic change in appearance from initially rather
diffuse to later more compacted, forming a tiny but dense spot
(Figure S2B). In summary, it seems that melanisation is highly
residual and strongly delayed compared with wild-type siblings,
consistent with low level derepression of melanogenic genes.
Figure 1. Sox10 is rapidly downregulated in differentiating melanocytes. A–D) Sox10 positive (A,B) and Sox10 negative (C,D) melanocytes
from 33 hpf embryo are indicated by arrows. Non-pigmented cells expressing Sox10 are indicated (*). E) sox10 in situ hybridisation on 33 hpf embryo
showing both sox10 positive (arrowhead) and sox10 negative (arrow) melanocytes. F) Time-course of percentage of melanocytes showing Sox10 or
sox10 expression during melanocyte differentiation stages. Expression was examined in 20 pigmented cells from each of 5 fish (i.e. n = 100) at each
time point.
doi:10.1371/journal.pgen.1002265.g001
Figure 2. Sox10 function in specification and differentiation of
neural crest. A) Sympathetic neuron development, based on [35].
B) Analogous model for melanocyte.
doi:10.1371/journal.pgen.1002265.g002
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Melanocyte differentiation gene derepression in sox10
mutants
From our model, we predicted that derepression of melanogenic
genes would be detected as increased expression in sox10 mutants
compared with mitfa mutants, and would be independent of Mitfa
function i.e. would persist in sox10; mitfa double mutants. We had
previously observed residual dct expression in dorsally-located cells
in sox10 mutants [36], but had not compared mitfa mutants. To
assess whether dct and other key melanocyte differentiation genes
were derepressed in sox10 mutants compared with mitfa mutants,
we performed a series of parallel in situ hybridisation studies using
four melanogenic genes, dct, tyrp1b, tyr and silva, on sox10 and mitfa
mutant embryos (Figure 3). Pilot experiments showed that
expression in mitfa mutants was extremely weak and was
undetectable in fish older than 36 hpf, so careful comparisons
were made at stages between 24 and 36 hpf (Table 1). In all cases,
marker expression in wild-types was very strong, but to test for low
level expression in mutants the in situs were stained longer,
resulting in higher background than normal. Mutant embryos
were developed in parallel with the same probe under identical
conditions; expression of all markers in the pigmented retinal
epithelium (PRE) was unaffected in each mutant and was used as
an internal control for the procedure on each embryo. We saw a
consistent pattern for all genes examined, with sox10 mutants
showing slightly more elevated and more consistently-detectable
expression (i.e. a higher proportion of embryos showed a signal)
and a longer duration (from 24 to 48+ hpf in sox10 mutants, but
from 24 to 30+ hpf in mitfa mutants) of detectable expression than
mitfa mutants (Figure 3 and Table 1). The differential expression of
dct, tyr and silva between the two mutants was striking; in contrast
effects on tyrp1b were subtle, with very little detectable expression
being seen (Figure 3), although this residual expression was more
consistent and more prolonged (Table 1) in sox10 mutants.
As an independent confirmation of these data, we used
quantitative real-time PCR on embryos at 30, 36 and 72 hpf
(Figure S3). As expected, expression levels of mitfa, dct and tyrp1b
are all much reduced in both mutants compared with wild-types.
However, consistent with our in situ hybridisation data, at 30 hpf,
but not at later stages, the expression levels of dct, and to a much
lesser extent tyrp1b, are significantly higher in sox10 mutants
compared with mitfa mutants, confirming the weak and transient
derepression of melanogenic genes in the sox10 mutant embryos.
We had previously shown that residual melanin in sox10
mutants was not due to low level expression of Mitfa, since
sox10;mitfa double mutants also showed residual melanisation. To
assess whether the low level derepression of melanocyte differen-
Figure 3. Residual melanocyte marker expression in sox10, mitfa, and sox10;mitfamutants. A–AB) Expression of dct, tyr, silva and tyrp1b in
wild-type (WT), sox10t3, mitfaw2 and sox10t3; mitfaw2 mutants is shown at 24 and 36 hpf as indicated. Insets in each panel show enlargement of area of
dorsal posterior trunk. Note the pronounced derepression of silva and dct, mild derepression of tyr, and minimal residual expression of tyrp1. Note
that all in situs were over-developed in order to detect low level expression.
doi:10.1371/journal.pgen.1002265.g003
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tiation genes was also independent of Mitfa, we repeated our in
situ hybridisation studies on sox10;mitfa double mutants generated
by crossing sox10+/t3;mitfaw2/w2 parents, so that all embryos were
mitfa homozygotes, and 25% were double homozygotes. We
focused on the 36 hpf stage, when mitfa mutants have consistently
lost expression, but sox10 mutants show detectable levels (Table 1);
thus, if derepression of melanocyte gene expression was indepen-
dent of Mitfa, we expected that 25% of embryos would show
‘rescue’ of differentiation gene expression. We found detectable
expression of the markers in nearly 25% of embryos (12/60, dct; 9/
48, silva; 9/49, tyr; 7/45, tyrp1b) from this cross (Figure 3), and
interpret these data as showing derepression in most sox10;mitfa
double mutants. We conclude that melanocyte differentiation gene
derepression is independent of mitfa.
Overexpression of Mitfa, but not Sox10, drives
precocious expression of melanocyte differentiation
genes
To test experimentally the conclusions from this loss of function
analysis we performed overexpression experiments in early
zebrafish embryos. Embryos were injected at 1-cell stage with
115 pg sox10 or 35 pg mitfa (initial trials showed 115 pg of mitfa to
induce severe lethality) sense RNA; as controls we used 115 pg of
sox10m618 or mitfaw2 RNA respectively which encode the loss of
function mutant forms. Injected embryos were examined for
induced gene expression by whole-mount in situ hybridisation at
an early (6 hpf) or later (10.5 hpf) time-point; note that each of
these times is prior to endogenous expression of any of the genes
assessed. Mitfa expression might be expected to drive expression of
most melanocyte differentiation genes, although data from mouse
studies might suggest that Mitf alone may be insufficient for some
genes, perhaps especially tyrosinase [24]. In contrast, our Sox10-
mediated repression model predicts that Mitfa alone will be
sufficient, but that whilst Sox10 alone would drive mitfa, Mitfa-
dependent expression of other melanocyte differentiation genes
(with the likely exception of tyrp1b) would be repressed by the
presence of Sox10. In all cases, the negative control RNAs induced
no gene expression. We observed a clear-cut distinction between
the effects of Sox10 and Mitfa overexpression (Figure 4).
Overexpression of wild-type mitfa mRNA resulted in strong
expression of all melanocyte differentiation genes by 6 hpf. In
contrast, wild-type sox10 induced mitfa, but no melanocyte
differentiation genes, by 6 hpf; by 10.5 hpf, tyrp1b was also
induced, whereas dct, tyr and silva were not. That this tyrp1b
expression was Mitfa-dependent was shown by injecting embryos
from a cross of homozygous mitfaw2 mutants with sox10; whilst mitfa
transcription was induced by 6 hpf, tyrp1b expression was never
seen at 10.5 hpf (data not shown). Our results were fully-consistent
with our Sox10-mediated repression model with the modification
that tyrp1b is insensitive to Sox10: Mitfa expression led to
melanocyte differentiation gene expression by the early time-
point, yet, whilst sox10 expression induced robust mitfa by the early
time-point, even at the later one only tyrp1b was expressed.
Co-expression of Sox10 represses Mitfa-dependent
expression of melanocyte differentiation genes
As a further test of our model, we asked whether co-injection of
both mitfa and sox10 RNA would give a Sox10-like pattern of
induction, but at the early time-point. Embryos were injected at 1-
cell stage with 115 pg sox10 and 35 pg mitfa sense RNA; control
embryos were injected with 115 pg of both sox10m618 and mitfaw2
RNA. Again the result was clear-cut; tyrp1b expression was readily
detected at 6 hpf, whereas dct, silva and tyr were not (Figure 5). We
conclude that Sox10 expression can repress the Mitfa-mediated
expression of most of the melanocyte differentiation genes tested,
but that tyrp1b expression is resistant to this effect, and that the
timing of tyrp1b expression is limited by mitfa expression.
Mitfa regulates sox10 transcription
Our simple melanocyte GRN predicts that loss of Sox10
expression results, directly or indirectly, from expression of Mitfa.
There are no published reports of Mitf (positively or negatively)
regulating sox10 expression, but we observed strong transcriptional
activation of sox10 when Mitfa was overexpressed in early
zebrafish embryos (Figure 4). This result was surprising since it
is in direct contradiction to the predictions of our model, although
it does suggest the possibility of Mitfa-mediated sox10 regulation in
vivo. To begin to assess whether this might be direct regulation of
the sox10 promoter by Mitfa, we asked whether GFP was activated
in the Tg(-7.2sox10:GFP) reporter line, in which a 7.2 kb fragment
of the promoter proximal region of sox10 genomic DNA drives
GFP expression [37]. In the presence of mitfa overexpression, we
noted clear GFP expression in transgenic fish at both an early time
point (6 hpf), as well as a later (10.5 hpf) one (Figure 6; Table 2),
consistent with possible direct regulation.
In contrast, in the same experiment, very few (6%) embryos
injected with sox10 RNA showed GFP expression at 6 hpf,
whereas essentially all transgenic embryos showed GFP by
10.5 hpf, consistent with the idea that Sox10 does not directly
regulate this reporter construct, but that Mitfa expression induced
Table 1. Quantitation of numbers of mutant embryos showing residual marker gene expression.
Marker Genotype 24 hpf 30 hpf 36 hpf 42 hpf 48 hpf 54 hpf 60 hpf
silva sox10 10/10 12/12 14/14 14/14 18/20 12/16 0/11
mitfa 2/6 5/12 0/7 n.d. n.d. n.d. n.d.
dct sox10 14/14 12/12 14/15 8/8 8/16 1/11 0/12
mitfa 0/6 5/12 0/10 n.d. n.d. n.d. n.d.
tyrosinase sox10 11/11 17/17 10/11 15/17 5/13 3/16 0/11
mitfa 6/6 10/10 0/8 n.d. n.d. n.d. n.d.
tyrp1b sox10 12/12 8/8 7/9 7/7 2/6 0/1 0/8
mitfa 6/9 0/11 0/11 n.d. n.d. n.d. n.d.
Number of homozygous mutant embryos showing detectable expression by in situ hybridisation of named marker gene is given out of total number of mutants
examined. Font reflects percentage with residual expression: 90–100%; 0–89%; n.d., not determined.
doi:10.1371/journal.pgen.1002265.t001
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by Sox10 can do so. To test this suggestion that sox10 mRNA only
results in expression of the Tg(-7.2sox10:GFP) transgene via
production of Mitfa, we asked whether expression of the transgene
fails in mitfa mutant embryos. Thus, we repeated the experiment
from Figure 6 in mitfa mutant, Tg(-7.2sox10:GFP) embryos. As a
positive control, we injected Tg(-7.2sox10:GFP);mitfaw2/w2 embryos
Figure 4. Induction of Mitfa-responsive genes is largely suppressed by Sox10. Representative groups of wild-type embryos are shown after
injection of mRNA as indicated to left (mitfa (A) and sox10, assayed at 6 hpf (B) or 10.5 hpf (C)), raised to stage indicated, then fixed and processed by
in situ hybridisation to detect genes named above panels (purple). Arrowheads indicate specific signal above background levels. D) Data is quantified
as percentage of injected embryos showing expression in graphs at right (n.44 in each case).
doi:10.1371/journal.pgen.1002265.g004
Figure 5. Co-expression of Sox10 and Mitfa represses most Mitfa-dependent expression of melanocyte differentiation genes.
A) Representative groups of wild-type embryos injected with sox10 and mitfa mRNA were fixed at 6 hpf and processed for whole-mount in situ
hybridisation to detect transcripts of genes indicated. B) Data is quantified as percentage of injected embryos (n.52 in each case).
doi:10.1371/journal.pgen.1002265.g005
Melanocyte Gene Regulatory Network
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with mitfa RNA; this frequently resulted in GFP expression at both
6 hpf (31/108 (29%) injected embryos) and 10.5 hpf (27/111
(24%)). In contrast, injection of sox10 mRNA in mitfa mutants did
not result in GFP expression at either 6 hpf (1/112 (1%)) or
10.5 hpf (0/105 (0%)). Interestingly, these data suggest that, in
contrast to dct and other differentiation genes, Mitfa-dependent
expression of sox10 is not repressed by the presence of Sox10.
The 7.2 kb of sox10 regulatory sequences in the Tg(-
7.2sox10:GFP) transgene contains 6 concensus M boxes, making
it plausible that Mitfa binds directly to this promoter. To begin to
narrow the region of the sox10 promoter likely to mediate this
response to Mitfa, we repeated these experiments in the Tg(-
4.9sox10:GFP) line [28] in which the 59 three M boxes are absent.
Interestingly, this transgene shows no response to injected Mitfa at
6 hpf (Figure S4).
Our data suggest that Mitfa can regulate sox10 expression, but
these experiments, examining the reporter in the context of
zebrafish blastomeres, do not necessarily reflect the promoter’s
response in melanoblasts. To address more directly how sox10
expression might be regulated by Mitfa in the endogenous
situation i.e. in the melanocyte lineage, we examined sox10
expression in mitfa mutants; if Mitfa is necessary for repression of
sox10 we predicted that mitfa mutants should show persistent sox10
expression. We examined mitfa mutants at 72 hpf, a stage when
wild-type embryos show no detectable sox10 expression in
melanocytes, but show strong expression in the peripheral nervous
system and ear (Figure 7A, 7B). In mitfa mutants, in addition to the
peripheral nervous system expression, we see readily detectable
sox10 expression in the position of the dorsal stripe (Figure 7D, 7E).
Furthermore, in mitfa mutants we also see a similar pattern of mitfa
expression in this same region (Figure 7F), strongly suggesting that
these cells are neural crest-derived melanocyte precursors that are
unable to differentiate due to the lack of functional Mitfa protein.
We tentatively conclude that Mitfa can regulate the sox10
promoter, and that this interaction is likely to have a repressive
function in vivo in differentiating melanocytes.
In considering whether any known factors might contribute to
this loss of sox10 expression in melanocytes, we noted the
persistence of sox10 expression described in colgate/hdac1 mutants
[38]. Histone deacetylase1 is a component of multiple complexes
that modify chromatin, resulting in selective repression of gene
expression. Consistent with the predictions of our model, hdac1
mutants show both persistent sox10 expression in neural crest cells
and poor melanocyte differentiation, although the connection
between these phenotypes was not addressed. To assess whether
persistent sox10 expression in melanocytes was associated with the
delay in differentiation, we used chemical inhibition of histone
deacetylase function [39] at the time of early melanocyte
differentiation, asking whether this resulted in poor melanocyte
differentiation and if this correlated with persistence of sox10
expression. Trichostatin A was applied in each of four time
windows: 12–48 hpf, 24–48 hpf, 30–48 hpf and 36–48 hpf.
Embryos treated in the 12–48 hpf window showed severe
morphological defects, lacking anterior head, but also showed a
dramatic reduction in melanocyte pigmentation (data not shown).
Those treated from 24–48 hpf again showed severe reductions in
melanocyte differentiation (Figure 8D–8F). Although these
embryos were of normal morphology, they did appear to show
slight retardation, having a morphology similar to approximately
36 hpf embryos. However, comparison of the degree of melani-
sation of an untreated 36 hpf embryo with the nominally 48 hpf
Trichostatin A-treated embryos indicated a clear reduction
beyond that expected from delayed development. Later treatment
windows showed only weak effects on melanocyte differentiation
(data not shown). Using in situ hybridisation we were further able
to show that treated embryos showed substantially elevated levels
of persistent sox10 expression in melanocytes (Figure 8N, 8Q).
Furthermore, our model requires Hdac-mediated repression of
sox10 expression to be Mitfa-dependent; hence it predicts that
Trichostatin A treatment of mitfa mutants would not result in
further elevation of sox10 levels above those of untreated mitfa
mutant controls. An experimental test of this prediction showed
that, indeed, sox10 expression in mitfa mutant embryos is not
further elevated by Trichostatin A treatment (Figure S5).
Taken together, our data lead us to conclude that repression of
sox10 expression in the melanocyte lineage is both Mitfa-
dependent and Hdac-dependent, (most likely mediated by Hdac1
[38]), and that these mechanisms contribute to the differentiation
of zebrafish melanocytes in vivo.
Mathematical modelling and refinement of the
melanocyte GRN
Our experimental data was consistent with the major
predictions of the simple melanocyte GRN that we had proposed.
To assess the GRN more rigorously, and to develop a more
quantitative understanding of the model, we turned to mathemat-
Figure 6. Mitfa-dependent activation of sox10 expression.
Tg(-7.2sox10:GFP) embryos were injected with RNA encoding wild-type
or w2 mutant mitfa (A) or wild-type or L142Q mutant sox10 (B).
Representative embryos are shown at 10.5 hpf, with GFP expression
detectable in those injected with wild-type, but not mutant forms. For
quantitation, see Table 2.
doi:10.1371/journal.pgen.1002265.g006
Table 2. Expression of GFP after injection of embryos from
Tg(-7.2sox10:GFP) outcross.*
RNA 6 hpf 10.5 hpf
mitfa 94/257 37% 68/152 45%
mitfa(w2) 0/118 0% 0/78 0%
sox10 20/319 6% 95/193 49%
sox10(L142Q) 0/120 0% 0/80 0%
*NB Only 50% of embryos from this cross would be transgenic, thus maximum
percentage GFP+ embryos expected is 50%.
doi:10.1371/journal.pgen.1002265.t002
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ical modelling. We constructed a simple dynamical model of the
GRN based upon ordinary differential equations, where the
transcript concentrations were considered as dynamic variables.
Our model aimed to describe the mutual regulation of the genes
involved in the GRN by simple activatory and repressive
dynamics, and the response of the GRN to external activatory
signals, designated Factor A. Studies of both mouse and zebrafish
have identified multiple enhancers that drive sox10 gene expression
in neural crest and its derivatives [37,40,41,42,43]. The factors
binding those enhancers are only poorly characterised in both
species, but may include Lef/Tcf (downstream of Wnt signalling),
Sox9, FoxD3, Pax and AP2. Since this regulation is poorly
understood, for the purposes of our modelling we combine these
factors into one composite Factor A. It is currently unclear
whether in a neural crest cell context these signals are merely
transient, or are constantly available. However, given the highly
Figure 7. Mitfa-dependent repression of sox10 expression in neural crest.Whole-mount in situ hybridisation shows prominent expression of
sox10 in peripheral glia and ear in mutants (D) and WT siblings (A); expression in WT melanocytes is undetectable (B), but mitfa mutants show
prominent expression in many cells in the position of the dorsal stripe (E). (C, F) At this same stage expression of mitfa in WT siblings is undetectable
under conditions used in this experiment (C), but can be shown by enhancing sensitivity by increasing PTU inhibition of melanisation and extending
the signal development time (C, inset).Mitfa expression is clearly enhanced in mitfa mutants (F). Note that WTs have been treated with 0.00075% PTU
to limit melanisation. B,C,E,F) dorsal views of posterior trunk, focused just above spinal cord. Scale bars, 100 mm.
doi:10.1371/journal.pgen.1002265.g007
Figure 8. Hdac inhibition with Trichostatin A decreases melanocyte differentiation and prolongs sox10 expression in neural crest
cells. A–I) Live embryos, showing close-ups of head (B,E,H) or yolk sac (C,F,I). (A–C) DMSO control embryo, (D–F) embryos treated with 1 mM
Trichostatin A from 24–48 hpf (D–F). Note that whilst all are at 48 hpf nominal age, the Hdac inhibited embryos show morphological retardation,
closely resembling 36 hpf untreated fish (G–I). Note that control 36 hpf untreated embryos (G–I) show significantly more melanisation than Hdac
inhibitor-treated fish, indicating Hdac inhibition has specific effect on melanisation beyond simply general retardation. J–R) In situ hybridisation with
sox10 probe showing elevated sox10 expression in premigratory (arrow, N) and migrating neural crest cells of Hdac inhibitor-treated fish (M–O)
compared with DMSO controls (J–L). Note that sox10 expression is elevated even when compared with morphologically-matched 36 hpf embryos
(P–R), and is thus not simply an effect of general retardation. Scale bar: 100 mm.
doi:10.1371/journal.pgen.1002265.g008
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dispersive nature of neural crest cells, we might assume external
signals, like Wnt, may be rather transient. Similarly, zebrafish sox9,
sox10, foxd3, pax and tfap2 are all downregulated in neural crest
cells as they differentiate into melanocytes [34,44–48]; this work).
Nevertheless, the data from mitfa mutants in Figure 7 indicate that,
at least in the vicinity of the dorsal neural tube, one or more
components of Factor A remain present at 72 hpf at least.
Consequently, for the purposes of our modelling studies, we
assumed that Factor A was constant throughout embryonic
development.
We explored the rigorous predictions of this initial melanocyte
GRN (Model A, Figure 9A) by direct simulation with a widespread
exploration of parameter space. Given the lack of quantitative
knowledge of most parameters, we restricted ourselves to assessing
under which conditions (i.e. parameter value sets) the model
predicted i) the long-term maintenance of mitfa expression, ii) an
initial increase of sox10, leading to its maximal expression at
intermediate times, and iii) long-term loss (or downregulation, i.e.
below a detection threshold) of sox10 expression, as we have
observed in differentiating melanocytes. Direct numerical integra-
tion of the ODE system of Model A revealed that the model
predicts that both mitfa and sox10 expression are maintained
(Figure 9B). However, we found that no parameter settings
allowed us to obtain an appreciable difference between sox10
maximal expression and its steady-state value (see Figure S6), as
implied by requirements ii) and iii) above. Maintenance of both
mitfa and sox10 arises because the sox10-inducing signals (Factor A)
are maintained, and these in turn maintain Mitfa expression. Our
experimental data above indicates that sox10-inducing signals do
seem to persist, at least in the vicinity of the neural tube. However,
we note that experimentally, maintenance of Mitfa can be
uncoupled from production of Sox10. Our previous study showed
that in sox10 mutant neural crest, transient expression of mitfa is
sufficient to generate stable (to 5 dpf at least) melanocyte
differentiation (Elworthy et al, 2003 [16]). Since this demonstrates
that stable melanocyte differentiation can occur in the absence of
Sox10 activity if Mitfa is provided even transiently, we rejected
Model A as too simplistic. In addition, we noted that it did not
incorporate the complexities of Mitfa-mediated regulation of
Sox10 as revealed by our experimental studies.
Consequently, we explored the features of a revised model
(Model B, Figure 9A) incorporating modifications expected to
correct these deficiencies. Firstly, we introduce a Sox10-indepen-
dent positive feedback loop on Mitfa (Factor Y). Secondly, we add
our demonstration that Mitfa-dependent activation of Hdac
contributes to the repression of Sox10.
Model B predicts that in mitfa mutant embryos, mitfa
transcription should be substantially decreased, due to the absence
of the positive feedback through Factor Y. In situ hybridisation
shows that mitfa expression in mitfaw2 mutants is distinctly
decreased at 30 and 36 hpf ([13], and data not shown), but given
that this mutant results in a premature stop codon, nonsense-
mediated decay might also explain the lowered mRNA levels. We
thus supplemented these observations with analysis of embryos
homozygous for the single amino acid substitution (I121S) allele,
mitfab692 [49]. In these mutants, we again observed an unambig-
uous substantial reduction in the levels of mitfa transcripts in the
mutant embryos (Figure 10A, 10B), thus providing support for the
biological validity of Factor Y.
Mitfa itself is a clear candidate for Factor Y, and indeed in
mouse Mitf functions in conjunction with Lef1 and b-catenin to
regulate the Mitf promoter [50]. As an initial test whether Mitfa
might regulate its own promoter, we asked whether injection of
mitfa mRNA would induce transcription of the endogenous mitfa
gene. We used an in situ hybridisation probe for the 39-UTR of
mitfa, since the injected mRNA lacks these sequences, as well as
examining dct induction as a positive control for Mitfa activity. We
saw induction of both dct and mitfa expression upon injection of
RNA encoding WT mitfa (Figure 10C, 10D, 10G, 10H), whereas
neither were seen after injection of RNA encoding either of the
Mitfa mutants, Mitfa(b692) or Mitfa(w2) (Figure 10E, 10F; data
not shown). We conclude that a Sox10-independent, Mitfa-
dependent Factor Y, predicted from mathematical modelling (and
perhaps Mitfa itself), is likely to play a major role in maintaining
melanocyte differentiation.
Contrary to our intuition, mathematical simulation of Model B
showed that this revised model still failed to generate the required
downregulation of sox10 under conditions where mitfa was
maintained (see Figure S7). Furthermore, it failed to predict two
aspects of the phenotype in sox10 mutant embryos. We found that
three further refinements to produce a third model (Model C,
Figure 9A) were required for the model to reproduce the
experimentally-demonstrated behaviour, as we discuss in the next
section.
Further refinement of the melanocyte GRN is required to
explain the wild-type and mutant phenotypes
The first modification required is a change to the way that
Hdac1-mediated repression functions on sox10 expression. In
Model B, we postulated that Hdac1 represses Mitfa-dependent
sox10 transcription. However, we found that this was inadequate to
allow repression of sox10 expression in the wild-type (Figure 9C),
since constant Factor A persists (Figure S7). In this context, the
identification of Hdac as a repressive factor becomes rather
striking, since the effects of deacetylation might be expected to
affect multiple enhancer elements. As we have noted experimen-
tally, sox10 expression is repressed in differentiating melanocytes,
so in Model C we show Hdac as repressing Factor A-dependent
sox10 expression, as well as Mitfa-dependent activation of sox10
transcription (Figure 9A). This model now reproduces the wild-
type observations (Figure 9D and Figure S8).
Secondly, we found that it is crucial to incorporate a threshold
response within the Factor Y-mediated feedback in Model B. In
the absence of such a threshold, the positive feedback of Factor Y
ensures that in sox10 mutants the absence of melanocyte
differentiation is only an unstable state associated with [mitfa] = 0,
since even the lowest level expression of mitfa would be expected to
trigger positive feedback leading to high level mitfa expression and
subsequent melanocyte differentiation (Figure 9C, sox10+Mitfa).
The biological observations are unambiguous – even vaguely
normal looking melanocytes are exceptionally rare in sox10
mutants (RNK, pers. obs.) – suggesting that the positive feedback
loop with Factor Y must exhibit threshold behaviour, so that the
[mitfa] = 0 state is stabilised at low levels of Mitfa or of Y. In both
sox10 and mitfa mutants expressing Mitfa under the sox10
promoter, melanocyte rescue is relatively unlikely (70% of
embryos show no melanocytes, and most embryos showing rescue
show ,10 melanocytes per embryo [16]), but when it does occur
melanocyte morphology and differentiation appear normal,
consistent with the GRN being bistable. To account for this
behaviour, we have incorporated a threshold response to the
Factor Y feedback loop.
Thirdly, Model B failed to predict the low level derepression of
melanocyte differentiation genes in sox10 or sox10;mitfa double
mutants (data not shown). One solution to this problem, a Sox10-
independent Factor Z driving (low level) expression of melanocyte
differentiation genes, is incorporated into Model C (Figure 9A).
Our efforts to model Factor Z initially assumed that it was driven
Melanocyte Gene Regulatory Network
PLoS Genetics | www.plosgenetics.org 9 September 2011 | Volume 7 | Issue 9 | e1002265
Figure 9. Mathematical modelling and development of the melanocyte GRN. A) Three versions of the melanocyte GRN have been modelled;
Models B and C are derived from A, and provide possible solutions to incompatibilities of earlier models with the experimental data. See text for further
details. B–D) Simulated output of Model A (B), Model B (C) and Model C (D) in wild-type (WT) embryos or in mitfa, sox10 and sox10;mitfa mutants. Lower
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by Factor A, and thus remained constant. However, under these
assumptions, we were unable to reproduce the very weak and
transient expression of differentiation genes observed experimen-
tally. Instead, we made the assumption that Factor Z is activated
by an unknown Factor B, and Factor B is only transiently
expressed in the melanocyte lineage. Mathematical exploration of
panel of (C) shows sox10mutant in which small amount of Mitfa is provided exogenously (red arrow), mimicking melanocyte rescue experiment (Elworthy
et al, 2003 [16]). Graphs plot behaviour of Model for choice of parameters compatible with experimental obervations; shown are changes in gene product
concentration (nM) against time (hpf). Parameter values used here are as follows. The initial A and B pulses are characterized by A0~B0~1(nM),
b~2(hrs)21, tA~t1~12 hpf, and t2~24 hpf. Furthermore maximal expression levels and degradation rates were fixed respectively at
gSox10~0:3,gMitfa~0:3,gX~0:3,gY~0:15,gZ~0:1,gTyrp1~3:1,gDct~0:3,gHdac1~0:3 (all values in nM/hrs) and dSox10~0:3,dMitfa~0:3,dX~0:1,dY~0:2,
dZ~0:2,dTyrp1~0:2,dDct~0:1,dHdac1~0:03 (all values in (hrs)
21) in all models. Specific parameters for the different models were the following. Model A:
a0~2:2,a1~1:0,b0~1:3,b1~1:2,c
(1)
0 ~1:5,c
(1)
1 ~1:0,c
(2)
0 ~1:0,c
(2)
1 ~0:8, g0~1:0,g1~1:0,z0~1:0,z1~1:2. Model B: a0~2:2,a1~1:0,b0~1:3,b1~1:2,
c
(1)
0 ~1:5,c
(1)
1 ~1:0,c
(2)
0 ~1:0,c
(2)
1 ~0:8, d0~1:6,d1~0:5,s0~1:6,s1~1:1,m0~0:1,m1~1:3,l0~1:0,l1~1:0,n0~1:0,n1~1:2, q0~0:1,q1~0:5,j0~1:6,
j1~1:1. Model C: The same as Model B, with r0~1:0,r1~0:5,e0~0:2,e1~1:3,q0~2:0,q1~0:1. (All values in (nM ? hrs)
21 for binding constants and in
(hrs)21 for unbinding constants respectively.) Other parameters include k1~1:0(nM
21 hrs21), k2~1:0(hrs
21), threshold values M* for Mitfa and Y* for
Factor Y, M*=Y*=0.01 (nM).
doi:10.1371/journal.pgen.1002265.g009
Figure 10. Mitfa-dependent maintenance of mitfa expression. A,B) Expression of Mitfa is reduced in mitfab692 mutant. A, B) Embryos from
incross of mitfa heterozygotes were treated with PTU and processed for in situ hybridization with mitfa probes at 30 hpf stage. A majority (53/69;
73%) showed normal strong mitfa expression and were presumed wild-type siblings (A, WT), whereas 33/124 (27%) had weakened expression and
were presumed mitfa mutants (B). C–J) Injection of RNA encoding WT Mitfa drives ectopic expression of dct (C,G) and mitfa (D,H) at both 6 hpf (C,D)
and 10.5 hpf (G,H), whereas RNA encoding the Mitfa(b692) mutant form does not (E,F,I,J). Expression of the endogenous mitfa gene is detected using
an anti-sense probe corresponding to the 39 UTR of the gene, a sequence absent from the injected RNA. Scale bar:100 mm.
doi:10.1371/journal.pgen.1002265.g010
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this model shows that, whilst the non-zero wild-type steady state
seen before in Model B is conserved, Model C also reproduces the
gene expression patterns seen in sox10, mitfa and sox10;mitfa
mutants (Figure 9D). In particular, expression of dct (representing
the melanocyte differentiation genes repressed by Sox10) is seen at
low levels in mitfa, sox10 and sox10;mitfa mutants, but this is weakest
and most transient in mitfa mutants.
Sox9b has the properties of Factor Z
This modelling is only useful in so far as it allows us to correctly
predict novel features of the biology. We chose to explore
candidates for Factor Z. Such genes would have no prominent role
in wild-type melanocytes (i.e. loss of gene function would not have
a melanisation defect), but they would need to be expressed in
neural crest cells and to drive low level melanisation in sox10
mutants; in addition they would be only transiently expressed in
melanocyte progenitors.
In adult human melanocytes SOX9 is likely to regulate DCT
[30]. There are two zebrafish orthologues of SOX9, but neither
sox9a nor sox9b nor sox9a;sox9b mutants show a loss of melanisation
[34]. Unlike sox9a, sox9b is expressed in early neural crest cells, but
then is downregulated ahead of sox10 in progenitors for all except
craniofacial cartilage (data not shown; [34]). We used previously
published sox9b morpholinos [51] to address whether morpholino-
mediated knockdown of Sox9b would result in loss of residual
melanin in sox10 mutants (Figure 11). The numbers of residual
melanised cells in sox10 mutants at 2 days post fertilisation (dpf)
was significantly reduced in embryos injected with 0.5 ng of each
sox9b morpholino compared with embryos injected with sox9b
mismatch morpholinos (Figure 11A–11C). We deduce that Sox9b
can drive Sox10 and Mitfa-independent melanisation displayed by
sox10 mutants.
We conclude that Sox9b shows the characteristics predicted for
Factor Z and that it at least contributes to this role in zebrafish.
Furthermore, our data provides biological validation of Factor Z, a
second feature of the melanocyte GRN predicted as a result of the
mathematical modelling. We also note the transient expression of
sox9b in NCCs, broadly consistent with our deductions from the
modelling above.
Discussion
In this study we have used a combination of genetic
experimentation and mathematical modelling to build upon our
initial description of melanocyte specification under the control of
Sox10 [16]. We have considerably expanded and refined the GRN
associated with melanocyte specification and differentiation in
embryonic zebrafish (Figure 12). We have shown multiple new
features, including 1) Sox10-mediated repression of many Mitfa
target genes; 2) the transient nature of Sox10 expression in
differentiating melanocytes, resulting from 3) Mitfa-dependent
repression of Sox10, likely via 4) a mechanism involving Hdac1
complex; and 5) Sox10-independent weak activation of melano-
genesis genes.
An early comparison of the core GRN of melanocytes in mouse
and zebrafish had concluded that they were evolutionarily
divergent [24]. That comparison focused on a basic description
of the role of Sox10 in melanocyte differentiation, noting that in
zebrafish there was no requirement beyond melanocyte specifica-
tion (i.e. activation of mitfa), whereas it was required positively both
for melanocyte specification (Mitf expression) and differentiation
(Tyr expression) in mouse. The more extensive examination of the
zebrafish GRN presented here both supports the suggestion of
some evolutionary divergence in the role of Sox10, but also
identifies a series of new features that will need to be examined in
the mouse system.
The data in the Hou et al study show that Mitf is not sufficient
to rescue melanisation in Sox10 mutant neural crest cells, at least in
primary cultures of neural crest cells, since Sox10 function is also
required to drive Tyr expression [24]. Our data validate our
previous conclusion that ongoing Sox10 function is not necessary for
melanocyte differentiation in zebrafish in vivo, since mitfa
expression in early neural crest cells was sufficient to fully rescue
melanocyte differentiation, even up to 5 dpf [16]. However, we
now show that Sox10 does have a role beyond melanocyte
specification (i.e. transcriptional activation of mitfa), although it
appears to be purely repressive. Certainly, the effects of Sox10 on
Tyr expression in mouse (synergistic activation with Mitf) and
zebrafish (antagonistic repression) are in stark contrast. These data
now make untenable the conclusion reached by Hou et al that the
differences in the role of Sox10 might explain the differences in
timing of melanisation in mammals (late) and fish (early) [24].
Further work to define in much greater detail the melanocyte
GRN in each species will allow identification of the key differences
between them actually controlling the distinctive timing of
melanisation.
Our observations in zebrafish beg the question of whether there
is Sox10-dependent repression of melanocyte genes in vivo in
Figure 11. Sox9b is a component of the melanocyte GRN and shows properties consistent with Factor Z. Expression of residual melanin
is compared in sox10mutant embryos treated with sox9bmorpholinos (B, sox9bMOs) or with control 5 bp mismatch morpholinos (A, MM-sox9bMOs).
C) Quantitation confirms that weak residual melanin is significantly reduced by Sox9b knockdown compared to treatment with mismatch
morpholinos. Graph shows mean6s.e.m., n = 154 (MM-sox9b MOs), 159 (sox9bMOs). ***, p,0.0001.
doi:10.1371/journal.pgen.1002265.g011
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mouse. Such studies are hindered by issues of sensitivity of whole
mount in situ hybridization and the difficulties of directly
comparing gene expression levels in melanocytes of wild-type
and mutant strains, but one recent paper attempts to standardise
the analysis of gene expression for multiple melanocyte markers in
E11.5 mouse embryos. Using their semi-quantitative scoring
system, Gpnmb (but not Dct, Si, or Tyr) expression is detectable in
Sox10LacZ/LacZ mutants but not in MitfMi/Mi mutants [52],
providing a hint that Sox10-dependent repression of melanocyte
differentiation genes may occur in mouse.
It certainly seems surprising that two homologous cell-types,
with striking conserved phenotypic characteristics, might show
such a substantial change in their GRN. Comparison of GRNs in
an evolutionary context is still in its infancy, but already examples
of substantial differences between the circuitry of homologous cell-
types are known. For example, in echinoderm development,
conserved gene expression in homologous domains of sea urchins
and sea stars often results from divergent regulatory inputs i.e. the
output is conserved, but the regulatory mechanism has diverged
[53]. Conceptually, it is trivial to imagine how mutations in
regions near the binding site of an activatory transcription factor
might allow binding of a co-repressor at that promoter. It will be
exciting to identify the molecular basis for the change in Sox10
function.
But what might be the biological function of the Feed-Forward
Repression by Sox10? In the mouse sympathetic neuron, Kim et al
suggest that this circuitry delays differentiation and maintains
multipotency [35]. Delay of melanocyte differentiation and
maintenance of progenitor multipotency is an attractive hypothesis
in the zebrafish too. Recent study of an mitfa:GFP transgenic line
indicates that not all neural crest cells that turn on mitfa will
become melanocytes, since some will form iridophores instead
(Curran et al., 2010). Thus, in zebrafish expression of mitfa does
not represent commitment to the melanocyte lineage; the Feed-
Forward Repression loop we have defined might contribute to that
maintenance of multipotency in the early melanocyte precursor.
Loss of Sox10 expression would then be necessary for commitment
to a differentiated state. In this context, it is intriguing that mouse
melanocytes, which retain Sox10 expression, appear to have also
retained multipotency, which can be exhibited when isolated and
cultured [54].
We have proposed that Sox10 functions to delay melanocyte
differentiation in embryonic zebrafish. Likewise, a similar
conclusion was reached for the role of Pax3 in adult mouse
melanocyte stem cell differentiation. Thus Lang and colleagues
demonstrated that Pax3 acted with Sox10 to drive transcription of
Mitf, whilst feed-forward repression by Pax3 delayed expression of
dct [55]. Pax3 morphants are not described as having a dramatic
melanocyte differentiation phenotype, but the detailed timing of
melanocyte differentiation was not examined [44]. Our initial
investigations using Pax3 morpholinos (MN and RNK, data not
shown) have failed to detect an effect on either wild-type or sox10
mutant melanogenesis, so it remains unclear whether the role for
Pax3 is conserved in fish.
One key feature of the zebrafish melanocyte GRN that we have
uncovered is the rapid down-regulation of sox10 during early
differentiation. A major task will be to elucidate the molecular
basis for this. Our study only begins to address this issue, indicating
that sox10 repression in melanocytes is Mitfa-dependent, but leaves
open whether sox10 is a direct target of Mitfa. Development of
further tools for the zebrafish, especially good antibodies for Mitfa
to allow ChIP-chip or ChIP-seq studies, will allow this important
question to be addressed definitively. Our initial data provide a
strong hint that the effect of Mitf, whether direct or indirect, on
sox10 is highly context dependent; Mitfa activates the sox10
promoter in the context of embryonic blastomeres, whereas it
represses the same promoter in the context of melanoblasts. We
note that the 7.2 kb genomic DNA fragment in the Tg(-
7.2sox10:GFP) reporter that responds to Mitfa contains 6 consensus
M boxes, whereas 3 of these are missing in the Tg(-4.9sox10:GFP)
that does not [56]. Testing whether Mitfa directly regulates sox10
in vivo via one or more of the 59 M boxes is a priority for future
work.
We hypothesize that the presence of a repressive cofactor in
melanoblasts alters the effect of Mitfa on the sox10 promoter. Little
is known of repressive cofactors in zebrafish melanocyte
development. Zebrafish histone deacetylase1/colgate (hdac1/col) mu-
tants showed delayed melanocyte differentiation; whilst sox10
expression in early neural crest was indistinguishable from wild-
type, sox10 expression was prolonged to at least 52 hpf, although it
was unclear if these phenotypes were causally linked [38]. We have
shown here that chemical inhibition of Hdac function during the
phase of early melanocyte differentiation results in prolonged sox10
expression in differentiating neural crest cells, and in impaired
melanogenesis. This is strikingly consistent with the core GRN we
have identified here, and supports the hypothesis that Mitfa-
dependent repression of sox10 requires Hdac1. However hdac1
expression is both maternal and zygotic [57], so transcriptional
regulation of hdac1 itself by Mitfa is unlikely to explain the
repression of sox10 in differentiating melanocytes. We speculate
Figure 12. Revised melanocyte GRN derived from this study. Components of Factor Y (blue) and Z (red) are indicated. We propose that one
or more components of Hdac1-containing repression complex is regulated by Mitfa, and mediates Mitfa-dependent repression of sox10 expression.
doi:10.1371/journal.pgen.1002265.g012
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that Mitfa may regulate recruitment to the sox10 promoter of an
Hdac1 complex [58], resulting in deacetylation of this chromatin
and repression of sox10 transcription.
The identification of Mitfa-dependent activation of the Hdac
complex proved crucial to explain the repression of sox10
transcription. In our modelling we initially assumed that Mitfa-
dependent repression affected only the regulation by Mitfa itself,
switching it from an activator to a repressor. However, modelling
the GRN in this way proved ineffective, because it failed to shut-
down sox10 transcription, apparently due to the fact that whilst the
Mitfa influence was repressed, input from Factor A persisted, and
hence Factor A-dependent expression became dominant. The
realization that Hdac complex mediated the Mitfa-dependent
repression immediately provided a resolution to this problem,
since deacetylation would be expected to repress activity of many/
all enhancers of the sox10 gene, making it likely that Factor A-
dependent sox10 expression, as well as Mitfa-dependent expres-
sion, would be inactivated in the wild-type situation. In contrast, in
the mitfa mutant situation, Factor A remains, so that we see
persistent sox10 and mitfa expression, just as observed in vivo.
Satisfyingly, this was exactly the behaviour we saw when we
modeled the GRN in the light of this insight. Hence, whilst the
presence of Factor A seems to persist, as revealed by the mitfa
mutant phenotype, our intuition that the influence of Factor A
would be transient in the wild-type situation appears to be well-
founded, resulting from the global shut-down of sox10 transcrip-
tion mediated by Hdac complex.
We have demonstrated for the first time that in the presence of
Sox10, many Mitfa-mediated transcriptional responses are
repressed. At first glance, it is surprising therefore that when we
over-express Mitfa in zebrafish blastomeres, melanocyte differen-
tiation genes are expressed robustly, despite the observation that
sox10 is also expressed. We propose that the explanation lies in the
timing of expression of Sox10 protein. When sox10 mRNA is
injected alone, Sox10 protein forms before mitfa can be
transcribed. Thus, Mitfa protein is functioning in the context of
substantial amounts of Sox10; in contrast, when mitfa is expressed
alone, Mitfa protein is functioning before sox10 transcription and
hence is working in the absence of Sox10 protein. The test of this is
the coinjection of both sox10 and mitfa mRNAs; in this context
both Sox10 and Mitfa proteins would be formed together and
hence again Mitfa would be functioning in the context of Sox10
protein. The prediction is that melanocyte differentiation genes
would be repressed; this prediction is directly borne out by our
experimental test (Figure 5). We conclude that our data is, in fact,
consistent in suggesting that Sox10 represses Mitfa-mediated
melanocyte differentiation.
Nonetheless melanocyte differentiation in vivo occurs whilst
sox10 transcripts remain detectable (Figure 1). We propose that, in
part, the explanation lies in Sox10-mediated repression depending
more on the ratio of Sox10:Mitfa proteins: our preliminary data
exploring the effects of changed ratios of sox10:mitfa supports this
[56]. In mouse sympathetic neuron differentiation, Sox10 hetero-
zygotes show derepression of Phox2A, but normal expression of
MASH1 and Phox2B, indicating that here higher levels of Sox10
are required for repression of differentiation than for specification
[35]. In addition, the explanation likely lies in the complex
integration of multiple factors as inputs on melanocyte differen-
tiation gene expression. Thus, here we have identified Sox9b as an
unexpected factor driving melanocyte differentiation. Given that,
as we show here, sox9b expression is not detectable in
differentiating melanocytes, this role must be transient, and
restricted to the early phase of melanocyte development. Whilst
melanisation is consistently repressed in sox10 mutants injected
with sox9b morpholinos, effects on residual dct expression were
more variable; whereas sox10 mutant embryos injected with the
mismatch morpholino showed low level dct expression, this
expression was sometimes reduced in sox9b morphant;sox10
mutant embryos, although not statistically significant overall
(MN and RNK, data not shown). We suggest that at these early
stages of melanocyte differentiation, dct expression reflects the
integration of multiple activatory (Mitfa, Sox9b, others?) and
inhibitory (Sox10, others?) inputs. Our mathematical modelling
here (Figure 9D) shows that this scenario can generate a
convincing reproduction of our semi-quantitative in situ observa-
tions. The challenge for the future will be in vivo quantitation of
the various key parameters of the model in order to examine how
precisely the model and the in vivo situation match each other.
Our mathematical modelling approach, used iteratively with
experimental data, has made specific predictions about the
properties of currently unidentified factors in melanocyte differ-
entiation. Importantly, we illustrate the power of our systems
biology approach by experimentally identifying Sox9b as a factor
fulfilling the properties of Factor Z. Our data here on melanocytes
extends the evidence for partial redundancy of Sox10 and Sox9b
in neural crest development initially shown for sensory neurons
[28]. Indeed, we noticed that sox9b morphants also show
significantly reduced numbers of ‘escaper’ iridophores too (MN
and RNK, data not shown), suggesting this partial redundancy
between these closely-related transcription factors may be a
general feature.
Our modelling also implied the activity of a Sox10-independent,
Mitf-dependent transcriptional activator of Mitfa, Factor Y,
providing a positive feedback loop to allow stable melanocyte
differentiation. We demonstrate that in mitfa mutant zebrafish
embryos, mitfa expression is reduced compared with wild-type
siblings consistent with our suggestion of a role for Mitfa in
maintaining mitfa expression. Consistent with this, we also show
that overexpression of Mitfa results in rapid, precocious expression
of the endogenous mitfa gene. Likewise, while Mitf expression in
mouse E11.5 embryos is prominent throughout the body, in
MitfMi/Mi mutants it is weakened and only detectable in the tail,
the developmentally youngest region [52]. These data strongly
support the suggestion from our modelling that maintenance of
mitfa expression is (directly or indirectly) dependent upon Mitfa
function, and that this feedback is conserved in mouse melanocytes
too.
Apart from Sox10, several other transcription factors have been
shown to regulate Mitf [59]. One candidate for Factor Y is CREB,
acting downstream of elevated cAMP induced by Melanocyte
Stimulating Hormone (MSH)/Melanocortin Receptor 1 (Mc1R)
signalling [60]. MSH has a clear role in background adaptation,
and Mc1R expression is maintained throughout embryonic
development [61,62]. However, current evidence for the role of
Mc1R in melanisation in zebrafish based on morpholino
knockdown is conflicting [63,64]. In our attempts to reproduce
these morpholino studies we saw a transient decrease in
melanisation, consistent with [63], but this seemed to be in large
part due to embryonic retardation, indicating that, in agreement
with [64], Mc1R signalling in zebrafish is unlikely to play a major
role in melanocyte melanisation (LV and RNK, data not shown).
We conclude that Mc1R signalling is not likely to contribute to
Factor Y, at least in the embryonic melanocytes.
Understanding the mechanisms stabilizing the differentiated
melanocyte fate is likely to have particular relevance for our
understanding of melanoma. Levels of the steady state activity of
Mitf appear to be crucial to the melanoma phenotype, with high
Mitf activity associated with differentiation and lowered levels with
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proliferation and melanoma [65]. Several factors identified as
regulating Mitf in development, also play major roles in
melanoma; for example, WNT/b-catenin dependent regulation
of MITF transcription has been demonstrated by chromatin
immunoprecipitation and plays a major role in the transformed
phenotype by promoting both proliferation and survival of
melanoma cells [66]. A mouse melanoma model generated by
combining melanocyte-specific expression of both constitutively
active b-catenin and activated N-ras generates frequent melano-
mas [67]. In the context of our work, it is interesting that
melanocytes from this strain frequently become immortalised, and
do not fully pigment [67].
In conclusion, our systems biology approach has identified
several new and unexpected features to the core GRN underlying
melanocyte specification and differentiation in vivo. We have
demonstrated a role for Sox10 in antagonising Mitfa-dependent
differentiation; have firstly predicted, then identified Sox9b as part
of, a factor with a transient role in Mitfa-independent melanisation
observed in sox10 and sox10;mitfa mutants; have predicted and then
shown that mitfa expression is, directly or indirectly, Mitfa-
dependent; and have provided the first indication that Mitfa might
negatively regulate sox10 expression in differentiating melanocytes.
Both the latter mechanisms are likely to be major factors stabilising
differentiation of melanocytes in zebrafish. The stage is now set for
a comprehensive analysis of the zebrafish melanocyte GRN, by
incorporation into the model of other known and unknown
regulatory functions combined with a network analysis of the
motifs identified therein, in order to truly understand the basis for
stable differentiation of this medically-important cell-type. We
suggest that application of our approach to other medically-
important cell-types is likely to be valuable.
Materials and Methods
Ethics statement
This study was performed with the approval of the University of
Bath ethics committee and in full accordance with the Animals
(Scientific Procedures) Act 1986.
Fish husbandry
Embryos were obtained from natural crosses and staged according
to Kimmel et al. [68]. We used the sox10t3 allele [29], the mitfaw2 [13]
allele except where stated otherwise, when we used mitfab692 [49],
and the Tg(-4725sox10:GFP)ba3 and Tg(-4.9sox10:EGFP)ba2 lines
[28,37].
In situ hybridisation and antibody staining
RNA in situ hybridization was performed according to Thisse
et al. [69], except probes were not hydrolysed and embryos were
incubated at 68uC in hybridization steps. Probes used were sox10
[15], dct [36], mitfa [13], silva (ZIRC cb397; [70], tyrosinase [71],
tyrp1b (clone number 6894514 from Geneservice, GenBank
reference CB353867, subcloned as an EcoRI/XhoI fragment into
Bluescript), gch [72], xdh [72] and paics (Plasmid and probe
generated by T. Chipperfield and C. Nelson).
Antibody staining with anti-Sox10 (1:10000, [73]) and Alexa
Fluor 488 (1:2000, Invitrogen, A21206) was performed largely as
Ungos et al. [74].
Embryos were viewed using an Eclipse E800 (Nikon) using
either DIC or fluorescence microscopy as appropriate. Embryos
were scored for Sox10 and sox10 expression by scoring 20
pigmented melanocytes in each of 5 embryos at each time point.
RNA injection
One cell stage embryos were injected with RNA using standard
methods as in Dutton et al. [15]. RNA was produced and recovered
using the mMESSAGE mMACHINE and MEGAclear kits
(Ambion) from hs.sox10 and hs.sox10m618 templates linearized
with Asp718 [15] or CS2+mitfaWT and CS2+mitfaw2 linearised with
Not1 [13]. sox10, sox10m618 and mitfaw2 RNA were diluted to a
concentration of 25 ng/ml, mitfa RNA was diluted to 6.25 ng/ml
including 0.0005% Phenol Red. Embryos were injected with 4.6 nl
RNA and grown for 6 or 10.5 hours at 28.5uC. Embryos were then
processed for in situ hybridisation or scored for GFP fluorescence
using an MZ12 dissecting microscope (Leica).
Promoter analysis
DNA sequence was submitted to TRANSFAC public version
6.0 using the Pattern Search for Transcription Factor Binding
Sites (PATCH 1.0) interface. Parameters were set to look for
vertebrate transcription factor binding sites of 6 bp or more with
the maximum number of mismatches being set at zero [75].
Chemical inhibition
Trichostatin A (TSA, [R-(E,E)]-7-[4-(Dimethylamino)phenyl]-N-
hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide)(Sigma-Aldrich)
was kept as a 5 mM in DMSO stock solution (0.2 mm-filtered) at
220C. Batches of embryos were treated with 1 mM Trichostatin
A in Petri dishes, during each of four time windows (from 12 hpf
to 48 hpf, from 24 hpf to 48 hpf, from 30 hpf to 48 hpf and from
36 hpf to 48 hpf) at 28.5uC. Control embryos received equivalent
doses of DMSO alone. Melanocyte phenotypes of live embryos
were documented at 48 hpf under a Nikon E800 microscope;
embryos were anesthetized with Tricaine (Sigma-Aldrich) and
mounted on slides under coverslips in 30% methylcellulose.
Quantitative real-time PCR
RNAwas extracted from samples of 40 embryos of each genotype
(decapitated after anaesthesis with Tricaine) using TRIREAGENT
(Sigma-Aldrich, T9424). First strand cDNA was synthesized using
the Invitrogen First strand cDNA synthesis kit with Superscript III
and random hexamers. Real time quantitative PCR was performed
in duplicate using SYBR Green I PCR Master Mix (Roche) and a
Lightcycler II machine according to the manufacturer’s instruc-
tions. Primers were designed spanning an intron using Primer3
Plus software (http://www.bioinformatics.nl/cgi-bin/primer3plus/
primer3plus.cgi.). The following primers were used: gapdh: forward
ACCAACTGCCTGGCTCCT, reverse TACTTTGCCTAC-
AGCCTTGG; mitfa: forward CTGGACCATGTGGCAAGTTT,
reverse GAGGTTGTGGTTGTCCTTCT; dct: forward TCT-
TCCCACCTGTGACCAAT, reverse CTGATGTGTCCAGC-
TCTCCA; trp1b: forward CGACAACCTGGGATACACCT,
reverse AACCAGCACCACTGCAACTA. Gene expression was
normalized against zebrafish gapdh expression in wild-type embryos.
Quantitative RT-PCR data were analysed using the (DDCt) method
[76]. Student’s t-test with Bonferroni correction for multiple
comparison were performed using GraphPadPrism 5.0 to test the
null hypothesis that there was no significant difference in gene
expression levels between mitfa and sox10 mutants. In all tests,
difference was considered significant if p,0.017.
Mathematical modelling
We constructed a mathematical model for gene regulation as a
one stage process: binding and unbinding of transcription factors
(TFs) to DNA was assumed to regulate protein production in a
single step of synthesis, without explicit modelling of intermediate
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mRNA levels. The model was expressed in terms of a system of
ordinary differential equations (ODEs). Binding and unbinding of
TFs were described as faster processes than protein synthesis and
degradation. This allowed us to solve the transcript dynamics in
conditions of quasi-equilibrium for the TFs. The result was a
description of both activatory and repressive regulation in terms of
Hill-like functions. By using appropriate combinations of Hill
functions, Models A, B and C (Figure 9A) were then described
mathematically. The derivation is presented in the accompanying
Text S1.
Models were investigated by direct numerical integration and,
in the case of Model C for the sox10 mutant, by steady-state
analysis. The steady-state analysis was obtained by setting time
derivatives to zero, and by solving analytically the corresponding
set of algebraic equations. This gave information about the long
time behaviour of this GRN, and allowed us to draw conclusions
independent of the particular set of chosen parameters. The time-
dependent solution was computed numerically by using a standard
finite differences algorithm (Euler). Parameter values were chosen
so as to reproduce the sought behavior, constrained by available
experimental evidence whenever possible. For instance, knowledge
about typical time scales of the relevant concentrations fixed gene
expression and decay rates.
Furthermore, the robustness of our conclusions with respect to
the chosen parameter values was assessed by plotting the steady
state value of Mitfa, and the steady state and the maximal values of
Sox10, as functions of the different activatory and repressive
regulations between mitfa and sox10 in all studied models (see
Figures S6, S7, S8). Here our aim was not to identify a unique
parameter set that reproduced the experimental data, but rather to
assess to what extent our conclusions might be broadly
independent of the specifically chosen parameters. In this sense
our results should be taken as qualitative, given the lack of
knowledge of most parameter values, but still representative of
typical dynamical behavior.
Supporting Information
Figure S1 Neither sox9a nor sox9b are expressed in differentiated
melanocytes. Lateral views of whole embryos (left) and dorsal
views of dorsal stripe region (insets right, location indicated by
lettered bars) show 60 hpf (A,C) and 72 hpf (B, D) embryos. In C,
inset b shows a deeper focal plane than that in inset a. Embryos
were treated with PTU to allow detection of even very weak
signals. Scale bar 100 mm.
(TIF)
Figure S2 Residual melanised cells in sox10 mutants appear late
and then increase with time. A) Photographs of dorsal trunk of a
single embryo showing dynamic changes in residual melanised
cells. Note how initially many cells show diffuse melanin (arrows)
and how new melanised cells appear with time (arrowheads). B)
Photographs of single melanised cell at consecutive time-points,
showing change from diffuse melanin (41 hpf) to tiny, dense spot
(43 hpf). C) Graphical plot of mean6s.e. number of segments
containing residual melanised cells from a typical series of embryos
(n = 19).
(TIF)
Figure S3 Quantitative RT-PCR of mitfa, dct and trp1b
expression in wild-type (WT), mitfaw2 mutants and sox10t3 mutants.
Values shown are mean6s.d. at 30 hpf, 36 hpf and 72 hpf.
Expression levels in WT controls were normalised to GAPDH for
each sample, and expression is shown as percentage of WT
transcript expression levels normalised to GAPDH. Expression
levels that were statistically significantly elevated in sox10 mutants
compared with mitfa mutants are indicated (1-tailed t-test with
Bonferroni correction for multiple comparisons, **).
(TIF)
Figure S4 Mitfa-dependent regulation of sox10 transgenes
narrows candidate regulatory elements. RNA encoding wild-type
mitfa (WT) or the mutant form (w2) was injected into
Tg(sox10(7.2):gfp) (7.2) and Tg(sox10(4.9):gfp) (4.9) embryos. Note
that at 6 hpf, only the former, but not the latter, show GFP
induction. As a control, sibling embryos injected with the same
constructs were fixed and examined for induction of sox10; note
that embryos injected with the wild-type mitfa showed robust
induction of sox10 expression. Scale bar, 500 mm. For quantifica-
tion, see Table S1.
(TIF)
Figure S5 Hdac-dependent derepression of sox10 expression is
not seen in mitfa mutant embryos. A–F) In situ hybridisation with
sox10 probe showing similar levels of sox10 expression in
premigratory (arrow, C) and migrating (arrowhead, C) neural
crest cells of mitfa mutants whether treated with 1 mM Trichostatin
A from 24–48 hpf (B,D,F) or in stage-matched 36 hpf DMSO
control mitfa mutants (A,C,E). Compare effect in WT embryos
shown in Figure 8. Scale bar: 100 mm.
(TIF)
Figure S6 Exploration of parameter value dependency in Model
A. Concentrations (nM) of Mitfa (black) at steady state, of Sox10
(Red) at steady state, and of maximal expression of Sox10 (Blue)
during relaxation, as functions of activation of Sox10 by Factor A
(a), activation of Mitfa by Sox10 (c) and repression of Sox10 by
Mitfa (b). Here a= a0/a1, c= c0/c1 and b= b0/b1 represent
binding affinities, varied over a range of two orders of magnitude.
The difficulty of realizing a state of high Mitfa expression at steady
state, low steady state expression of Sox10, preceded by an
appreciably different Sox10 maximal value, leads to rejection of
Model A.
(TIF)
Figure S7 Exploration of parameter value dependency in Model
B. Concentrations (nM) of Mitfa (black) at steady state, of Sox10
(Red) at steady state, and of maximal expression of Sox10 (Blue)
during relaxation, as pair-wise functions of the affinities tuning the
Hdac1-mediated repression of Mitfa activation of Sox10 (j), and
the other regulatory interactions present in the Mitfa-Sox10
module. Here a, b, d, h, c represent activation of Sox10 by Factor
A, repression of Sox10 by Mitfa, activation of Mitfa by Factor Y,
activation of Hdac1 by Mitfa, and activation of Mitfa by Sox10,
respectively. As in Model A, Model B does not readily allow for
parameter combinations giving high values of Mitfa steady state
concentration, low values of Sox10 at steady state, and a
substantially elevated maximum of Sox10 during relaxation.
(TIF)
Figure S8 Exploration of parameter value dependency in Model
C. Concentrations (nM) of Mitfa (black) at steady state, of Sox10
(Red) at steady state, and of maximal expression of Sox10 (Blue)
during relaxation, as pair-wise functions of the affinities tuning the
Hdac1-mediated repression of Factor A activation of Sox10 (w),
and the other regulatory interactions present in the Mitfa-Sox10
module. Here a, b, d, h, c j represent activation of Sox10 by
Factor A, repression of Sox10 by Mitfa, activation of Factor Y by
Mitfa, activation of Hdac1 by Mitfa, activation of Mitfa by Sox10,
and Hdac1 repression of Mitfa activation of Sox10, respectively. In
contrast to Models A and B, Model C satisfies the requirements of
a high expression of Mitfa at steady state, low expression of Sox10
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at steady state, and pronounced Sox10 maximum at intermediate
times, over an extensive region of the parameter space.
(TIF)
Table S1 Expression of GFP or endogenous sox10 after injection
of embryos from Tg(-7.2sox10:GFP) and Tg(-4.9sox10:GFP) cross.
Embryos injected with mitfa or mitfa(w2) RNA were scored for
expression of sox10:GFP transgene by live observation of GFP
fluorescence or for endogenous sox10 by in situ hybridisation, and
expressed as a fraction of the total number of embryos examined.
(DOC)
Text S1 Detailed description of mathematical models.
(PDF)
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